Mylan Pharmaceuticals SWOT Analysis
Here is a detailed SWOT analysis of Mylan Pharmaceuticals covering strengths, weaknesses, opportunities and threats.
Mylan Pharmaceuticals Strengths
- Mylan has strong generic portfolio with more than 1000 individual products
- It has strong global presence in more than 150 countries
- Their major strength is vertically integrated supply chain
- Mylan has acquired generic business of Merck & Matrix pharmaceuticals which is largest generic Manufacturer in India
- It has more than 15,000 well trained employees
Above are the strengths in the SWOT Analysis of Mylan Pharmaceuticals. The strengths of Mylan Pharmaceuticals looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Mylan Pharmaceuticals Weaknesses
- Alleged litigations have sometimes impacted its public image
- Very limited portion of its revenue comes from foreign business
These were the weaknesses in the Mylan Pharmaceuticals SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Mylan Pharmaceuticals Opportunities
- Expiry of patent on Lipitor has open new business opportunities
- Increasing awareness about healthcare
- Increasing prevalence of chronic diseases such as cancer
Above we covered the opportunities in Mylan Pharmaceuticals SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Mylan Pharmaceuticals Threats
- Global economic slowdown
- More stringent patent protection laws
- Pending litigations
The threats in the SWOT Analysis of Mylan Pharmaceuticals are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Mylan Pharmaceuticals SWOT analysis.
About Mylan Pharmaceuticals
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Mylan Pharmaceuticals Overview | |
|---|---|
| Parent Company |
Mylan Pharmaceuticals |
| Category |
Pharmaceuticals |
| Sector | |
| Tagline/ Slogan |
Seeing is believing |
| USP |
It is third largest generics manufacturing company in U.S |
| Mylan Pharmaceuticals STP | |
| Segmentation |
API, nebulized respiratory or severe allergy medications & anti retroviral drugs |
| Target Market |
Healthcare professionals & doctors providing solutions in ART, respiratory diseases |
| Positioning |
Mylan is the company, which innovates to satisfy the unmet medical need & aims to provide 7 billion people of world medical solutions. |
Browse marketing analysis of more brands and companies similar to Mylan Pharmaceuticals. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
